Prognosis of Behavioral Addiction in Parkinson's Disease (PROBA-PD)

University Hospital, Strasbourg, France

Status: Terminated

Conditions: Addiction

Study type: Observational

Funder types: Other

Identifiers

NCT02671240

6246 (Other Identifier)

Details and patient eligibility

About

Our hypothesis is that the conventional treatment of Behavioral Addiction in Parkinson's disease is often not effective, and that affects the motor aspects (worsening akinéto-rigid syndrome and / or worsening of dyskinesia due to higher levodopa doses to compensate for the drop in behavioral addictions) and non-motor (withdrawal syndrome dopamine agonist) anxiously including apathy.

Our goal is to describe the natural history of Behavioral Addiction under the effect of the evolution of the disease and adapt treatment according to the prior art, through a study of a larger population of patients than in the few published studies.

Enrollment: 164 patients

Sex: All

Ages: 30+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age greater than or equal to 30 years
• Parkinson's disease according to the criteria of UKPDSBB
• Time evolution of the top disease or equal to 5 years

Exclusion criteria

• Lack of Parkinson's disease and atypical parkinsonism
• Patient not previously included in PD-BADGE

Trial design

164 participants in 2 patient groups

- Patients with behavioral addiction

- Patients with no behavioral addiction